Three-time Olympic medallist Roger Black did not want his athletics career to be defined by a lifelong heart issue, as he ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...

A late-breaking study presented today at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival ...

Objective In this study, the impact of regular training on left ventricle morphology in a group of athletes with bicuspid aortic valve (BAV) was evaluated. Design Longitudinal cohort study. A group of ...

The clinical trial’s final results could shake up the transcatheter aortic valve replacement (TAVR) market, according to GlobalData, a leading data and analytics company. According to GlobalData ...

As mentioned previously, medically managed treatment of severe aortic stenosis has a dismal prognosis, with an overall mean survival of 3 years from the onset of symptoms. [11,12] Surgical valve ...

Feb 27 (Reuters) - (This Feb. 25 Health Rounds newsletter excerpt has been corrected to indicate in the headline and the first item of the story that Sanofi is no longer involved in the drug's ...